CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Riccardo Bortoletto - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Riccardo Bortoletto

OPENALEX: A5014313202↗ORCID: 0000-0002-0125-4112↗

Affiliations

Organizations

King's College Londonauthorship · GB University of Veronaauthorship · IT

Public evidence

2 connected articles

The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis.2024 · Europe PMC Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.2022 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.